Cargando…
Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients
BACKGROUND: Antibody response to SARS-CoV-2 is a valuable biomarker for the assessment of the spread of the virus in a population and evaluation of the vaccine candidates. Recent data suggest that antibody levels also may have a prognostic significance in COVID-19. Most of the serological studies so...
Autores principales: | Plūme, Jānis, Galvanovskis, Artis, Šmite, Sindija, Romanchikova, Nadezhda, Zayakin, Pawel, Linē, Aija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012069/ https://www.ncbi.nlm.nih.gov/pubmed/35428263 http://dx.doi.org/10.1186/s12967-022-03382-y |
Ejemplares similares
-
Exercise-Induced Extracellular Vesicles Delay the Progression of Prostate Cancer
por: Sadovska, Lilite, et al.
Publicado: (2022) -
Extracellular Vesicles—A Source of RNA Biomarkers for the Detection of Breast Cancer in Liquid Biopsies
por: Zayakin, Pawel, et al.
Publicado: (2023) -
Lung on a Chip Development from Off-Stoichiometry Thiol–Ene Polymer
por: Rimsa, Roberts, et al.
Publicado: (2021) -
Effects of urinary extracellular vesicles from prostate cancer patients on the transcriptomes of cancer-associated and normal fibroblasts
por: Sadovska, Lilite, et al.
Publicado: (2022) -
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
por: Lucane, Zane, et al.
Publicado: (2023)